FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 251 filers reported holding FATE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,053 | -58.6% | 1,440 | -7.0% | 0.00% | – |
| Q2 2023 | $7,373 | +23683.9% | 1,549 | -71.9% | 0.00% | – |
| Q1 2023 | $31 | +933.3% | 5,505 | +1735.0% | 0.00% | – |
| Q4 2022 | $3 | -100.0% | 300 | -87.8% | 0.00% | – |
| Q3 2022 | $51,000 | -1.9% | 2,462 | +17.2% | 0.00% | – |
| Q2 2022 | $52,000 | -42.9% | 2,100 | -11.0% | 0.00% | -100.0% |
| Q1 2022 | $91,000 | -13.3% | 2,360 | -7.1% | 0.00% | 0.0% |
| Q4 2021 | $105,000 | -39.0% | 2,540 | -12.4% | 0.00% | 0.0% |
| Q3 2021 | $172,000 | -36.1% | 2,900 | -6.5% | 0.00% | -50.0% |
| Q2 2021 | $269,000 | -7.6% | 3,100 | -12.2% | 0.00% | 0.0% |
| Q1 2021 | $291,000 | -18.5% | 3,530 | -10.2% | 0.00% | 0.0% |
| Q4 2020 | $357,000 | +264.3% | 3,930 | +60.1% | 0.00% | +100.0% |
| Q3 2020 | $98,000 | +415.8% | 2,455 | +342.3% | 0.00% | – |
| Q2 2020 | $19,000 | +58.3% | 555 | +5.7% | 0.00% | – |
| Q1 2020 | $12,000 | 0.0% | 525 | -12.5% | 0.00% | – |
| Q4 2019 | $12,000 | +33.3% | 600 | 0.0% | 0.00% | – |
| Q3 2019 | $9,000 | 0.0% | 600 | +39.5% | 0.00% | – |
| Q2 2019 | $9,000 | +12.5% | 430 | 0.0% | 0.00% | – |
| Q1 2019 | $8,000 | +33.3% | 430 | 0.0% | 0.00% | – |
| Q4 2018 | $6,000 | -14.3% | 430 | 0.0% | 0.00% | – |
| Q3 2018 | $7,000 | – | 430 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $46,987,000 | 60.92% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $278,604,000 | 36.08% |
| Darwin Global Management, Ltd. | 1,370,133 | $112,967,000 | 22.12% |
| Redmile Group, LLC | 12,957,222 | $1,068,323,000 | 15.05% |
| Copernicus Capital Management, LLC | 8,000 | $660,000 | 10.66% |
| Casdin Capital, LLC | 3,400,000 | $280,330,000 | 8.35% |
| Grosvenor Holdings, L.L.C. | 1,123,576 | $92,639,000 | 6.81% |
| DAFNA Capital Management LLC | 314,360 | $25,919,000 | 6.15% |
| Ally Bridge Group (NY) LLC | 270,000 | $22,262,000 | 4.27% |
| Ghost Tree Capital, LLC | 185,000 | $15,253,000 | 3.58% |